143 related articles for article (PubMed ID: 38537954)
1. Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
Aoyama T; Yukawa N; Saito A
Anticancer Res; 2024 Apr; 44(4):1335-1351. PubMed ID: 38537954
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Rino Y; Oshima T
Anticancer Res; 2023 Sep; 43(9):3849-3860. PubMed ID: 37648333
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment.
Aoyama T; Hara K; Kazama K; Maezawa Y
Anticancer Res; 2022 Nov; 42(11):5167-5180. PubMed ID: 36288879
[TBL] [Abstract][Full Text] [Related]
4. Liver resection for colorectal cancer metastases.
Gallinger S; Biagi JJ; Fletcher GG; Nhan C; Ruo L; McLeod RS
Curr Oncol; 2013 Jun; 20(3):e255-65. PubMed ID: 23737695
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment.
Aoyama T; Kazama K; Maezawa Y; Hara K
In Vivo; 2023; 37(1):22-35. PubMed ID: 36593006
[TBL] [Abstract][Full Text] [Related]
6. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.
Adam R; De Gramont A; Figueras J; Guthrie A; Kokudo N; Kunstlinger F; Loyer E; Poston G; Rougier P; Rubbia-Brandt L; Sobrero A; Tabernero J; Teh C; Van Cutsem E;
Oncologist; 2012; 17(10):1225-39. PubMed ID: 22962059
[TBL] [Abstract][Full Text] [Related]
7. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
[TBL] [Abstract][Full Text] [Related]
8. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
Booth CM; Nanji S; Wei X; Mackillop WJ
JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
[TBL] [Abstract][Full Text] [Related]
9. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
[TBL] [Abstract][Full Text] [Related]
10. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment strategies for colorectal liver metastases.
Birrer DL; Tschuor C; Reiner C; Fritsch R; Pfammatter T; Garcia Schüler H; Pavic M; De Oliveira M; Petrowsky H; Dutkowski P; Oberkofler C; Clavien PA
Swiss Med Wkly; 2021 Feb; 151():w20390. PubMed ID: 33631027
[TBL] [Abstract][Full Text] [Related]
12. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer.
Dutton SJ; Kenealy N; Love SB; Wasan HS; Sharma RA;
BMC Cancer; 2014 Jul; 14():497. PubMed ID: 25011439
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study.
Gallois C; Artru P; Lièvre A; Auclin E; Lecomte T; Locher C; Marthey L; Zaimi Y; Faroux R; Pernot S; Barret M; Taieb J
Eur J Cancer; 2019 Sep; 119():35-43. PubMed ID: 31415985
[TBL] [Abstract][Full Text] [Related]
14. Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.
Semrad TJ; Fahrni AR; Gong IY; Khatri VP
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S855-62. PubMed ID: 26100816
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary approach of colorectal liver metastases.
Juez I; Rubio C; Figueras J
Clin Transl Oncol; 2011 Oct; 13(10):721-7. PubMed ID: 21975333
[TBL] [Abstract][Full Text] [Related]
16. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Web Applications on Improving Nutritional Status of Patients with Colorectal Cancer.
Nunthanawanich P; Wichansawakun S; Luangjinda C; Hudthagosol C
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337693
[TBL] [Abstract][Full Text] [Related]
18. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
19. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
